StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Citi raises Arcus Biosciences price target to $50
October 21, 2026 3:56 AM
Citi analyst Yigal Nochomovitz raised his price target on Arcus Biosciences (NYSE: RCUS) to $50 from $45, while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
